DETECT GENOMIX Trademark

Trademark Overview


On Monday, October 26, 2020, a trademark application was filed for DETECT GENOMIX with the United States Patent and Trademark Office. The USPTO has given the DETECT GENOMIX trademark a serial number of 90277874. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, November 22, 2022. This trademark is owned by Detect Genomix, LLC. The DETECT GENOMIX trademark is filed in the Advertising, Business and Retail Services, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

maintaining a registry of genomic data used for neonatal, perinatal, and pediatric medical care and genetic counseling

Genetic testing for medical purposes; genetic counseling; clinical genomic services, namely, precision medical care for infants in neonatal and perinatal intensive care units, and for women with high-risk pregnancies in both ambulatory and acute care settings; providing perinatal and pediatric precision medical care

conducting clinical medical and translational research in the field of genomics
detect genomix

General Information


Serial Number90277874
Word MarkDETECT GENOMIX
Filing DateMonday, October 26, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, November 22, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Description of MarkThe mark consists of the stacked words DETECT GENOMIX with a double-helix design forming the final letter X.
Goods and Servicesmaintaining a registry of genomic data used for neonatal, perinatal, and pediatric medical care and genetic counseling
Goods and ServicesGenetic testing for medical purposes; genetic counseling; clinical genomic services, namely, precision medical care for infants in neonatal and perinatal intensive care units, and for women with high-risk pregnancies in both ambulatory and acute care settings; providing perinatal and pediatric precision medical care
Disclaimer with Predetermined Text"GENOMICS"
Goods and Servicesconducting clinical medical and translational research in the field of genomics

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, April 13, 2022
Primary Code035
First Use Anywhere DateTuesday, January 26, 2021
First Use In Commerce DateTuesday, January 26, 2021

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 15, 2020
Primary Code042
First Use Anywhere DateTuesday, January 26, 2021
First Use In Commerce DateTuesday, January 26, 2021

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, December 15, 2020
Primary Code044
First Use Anywhere DateTuesday, January 26, 2021
First Use In Commerce DateTuesday, January 26, 2021

Trademark Owner History


Party NameDetect Genomix, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressSunrise, FL 33323

Trademark Events


Event DateEvent Description
Tuesday, November 22, 2022ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, November 22, 2022ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Tuesday, November 22, 2022ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Tuesday, May 10, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, May 10, 2022NON-FINAL ACTION E-MAILED
Tuesday, May 10, 2022NON-FINAL ACTION WRITTEN
Wednesday, April 13, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, April 12, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, April 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, October 26, 2021NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Monday, October 25, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 25, 2021NON-FINAL ACTION E-MAILED
Monday, October 25, 2021USE AMENDMENT ACCEPTED
Monday, October 25, 2021NON-FINAL ACTION WRITTEN
Tuesday, October 5, 2021AMENDMENT TO USE PROCESSING COMPLETE
Tuesday, October 5, 2021USE AMENDMENT FILED
Monday, October 4, 2021TEAS AMENDMENT OF USE RECEIVED
Tuesday, October 5, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, October 5, 2021LETTER OF SUSPENSION E-MAILED
Tuesday, October 5, 2021SUSPENSION LETTER WRITTEN
Monday, October 4, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, October 4, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, October 4, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 2, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 2, 2021NON-FINAL ACTION E-MAILED
Friday, April 2, 2021NON-FINAL ACTION WRITTEN
Friday, March 26, 2021ASSIGNED TO EXAMINER
Wednesday, December 16, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, December 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, October 29, 2020NEW APPLICATION ENTERED IN TRAM